
|Articles|February 1, 2002
Daptomycin impressive against dual staph, strep skin infections
Chicago - Daptomycin (Cidecin), a novel lipopeptide antibiotic, showed a trend toward an improved clinical response compared to current standard therapy in the treatment of complicated skin and soft tissue (cSST) infections caused by dual infection with
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Global Hidradenitis Suppurativa Atlas (GHiSA) Finds HS Affects 1% of the World's Population
2
Delgocitinib Offers Targeted Relief for the Painful Burden of Chronic Hand Eczema
3
When Hives Do Not Quit: A Practical Update on Chronic Spontaneous Urticaria
4
Top 5 Articles of the Week: December 7-12
5


















